چاپ صفحه |  صفحه نخست سامانه |  نویسندگان |  اطلاعات تفضیلی |  دانلود مقاله | دانشگاه علوم پزشکی تبریز |
| نویسنده | نفر چندم مقاله |
|---|---|
| فریبا اسلامیان | دوم |
| رها مرکزی موقر | اول |
| نگار تلسچیان تبریزی | سوم |
| بهزاد ایزدسرشت | چهارم |
| شکیبا قلیان | پنجم |
| عنوان | متن |
|---|---|
| خلاصه مقاله | Background and Aim: The outbreak of novel severe acute respiratory syndrome coronavirus 2 (SARS- CoV2) in 2019, drew significant attention and effort as a global health concern. In spite of partial control of pandemic, it is still remained as one of the hot topics. The symptoms of COVID-19 varied widely from a mild respiratory involvement to multi organ failure or death. Neurological manifestations were reported as challenging features in COVID-19 patients. Four limbs weakness was one of the rare but significant complications following COVID-19 which we reported in our case series and looked for the underlying context using electrodiagnostic studies. Methods: We presented Six patients with the diagnosis of COVID-19, who developed concomitant quadriparesia. All of the patients were hospitalized in Imam Reza Hospital, Tabriz and were referred to Physical Medicine and Rehabilitation center for electrodiagnostic studies. After history taking and clinical examination the patients underwent EMG/NCS studies. Results: The interpretation of findings revealed 3 axonal variants of Guillain–Barré syndrome (GBS), including; 2 cases AMAN (acute motor axonal neuropathy), 1 case AMSAN (acute motor and sensory axonal neuropathy), 3 myopathies, including one combination of CIN/CIM (critical illness neuropathy/critical illness myopathy), one CIM and one acute polymyositis in these cases. Conclusion: Electrodiagnostic studies could play an important role in the diagnosis of neuromuscular disorders of coronavirus to facilitate correct treatment planning in COVID-19 patients. Since GBS and inflammatory myopathies have an autoimmune basis, the immunotherapies such as IVIG, steroids, plasma exchange and other novel treatments as hemoperfusion can provide promising recovery in respiratory function as well as neuromuscular activity among COVID-19 patients who have musculature paralysis concomitantly. However, all of these options are challenging and further clinical trials is needed. |
| کلمات کلیدی | Acute motor axonal neuropathy, COVID-19, Corona virus, Critical illness myopathy, Critical illness neuropathy, GBS, Quadriparesis |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| covid article abstract.pdf | 1402/04/09 | 206856 | دانلود |
| lecture certificate.pdf | 1402/04/09 | 241529 | دانلود |
| Certificate.aspx.pdf | 1402/04/09 | 257682 | دانلود |
